OR8B12 can engage in a variety of cellular mechanisms to enhance the activity of this protein. Forskolin, a well-known direct stimulator of adenylyl cyclase, can effectively raise cyclic AMP (cAMP) levels within cells. The increase in cAMP acts as a second messenger to activate protein kinase A (PKA), which is known to phosphorylate target proteins, including OR8B12, thereby enhancing its activity. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP, and likewise facilitates the activation of PKA that may lead to the phosphorylation and subsequent activation of OR8B12. Isoproterenol, a beta-adrenergic agonist, and Salbutamol, along with Terbutaline, both beta-2 adrenergic agonists, also raise cAMP levels through the activation of adenylyl cyclase, which signals downstream to activate PKA and thus, can activate OR8B12.
Epinephrine, another beta-adrenergic receptor agonist, shares this pathway of cAMP-mediated activation of PKA, providing a common mechanism through which these diverse chemicals can converge on the activation of OR8B12. Prostaglandin E2 (PGE2) operates through its own set of G protein-coupled receptors, yet still produces an increase in intracellular cAMP, offering yet another route to PKA activation and OR8B12 activity enhancement. Histamine and dopamine, each by binding to their respective G protein-coupled receptors, initiate a signaling cascade that results in elevated cAMP and activation of PKA, which can then phosphorylate and activate OR8B12. Adenosine and its non-selective agonist NECA, by activating adenosine receptors, also lead to raised cAMP levels, feeding into the same PKA-mediated activation of OR8B12. Lastly, Rolipram, by selectively inhibiting phosphodiesterase 4, prevents cAMP breakdown, thereby sustaining the activation signal to PKA, which can subsequently phosphorylate and activate OR8B12. Each of these chemicals, through their unique interactions with cellular signaling pathways, culminates in the activation of PKA, which is a pivotal kinase for the functional activation of the OR8B12 protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, leading to increased cAMP levels which activates PKA that can phosphorylate OR8B12, enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP by preventing its degradation, potentially leading to activation of OR8B12 through PKA-mediated phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that can increase cAMP levels by activating adenylyl cyclase, potentially leading to OR8B12 activation through PKA signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Prostaglandin E2 can activate G protein-coupled receptors which can increase intracellular cAMP, potentially leading to the activation of OR8B12 via PKA. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Activates G protein-coupled histamine receptors that can increase cAMP levels, potentially leading to activation of OR8B12 through PKA-dependent signaling. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Binds to dopamine receptors that can signal through G proteins to increase cAMP, which could lead to OR8B12 activation via PKA. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Activates adenosine G protein-coupled receptors which can increase cAMP, potentially leading to OR8B12 activation through PKA signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Activates beta-adrenergic receptors increasing cAMP and potentially leading to OR8B12 activation via PKA phosphorylation. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $92.00 $138.00 | ||
Beta-2 adrenergic agonist that leads to increased cAMP, potentially resulting in the activation of OR8B12 through PKA signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selective inhibitor of phosphodiesterase 4, increases cAMP levels, which could lead to activation of OR8B12 via PKA-dependent phosphorylation. |